PROCEPT BioRobotics Corporation PRCT
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 13.67% | 8.84% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.67% | 8.84% | |||
| Cost of Revenue | 19.99% | -2.94% | |||
| Gross Profit | 10.25% | 16.48% | |||
| SG&A Expenses | 7.04% | 11.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.82% | 7.74% | |||
| Operating Income | 7.10% | -5.04% | |||
| Income Before Tax | 15.51% | -6.83% | |||
| Income Tax Expenses | 318.60% | -122.63% | |||
| Earnings from Continuing Operations | 15.10% | -6.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.10% | -6.01% | |||
| EBIT | 7.10% | -5.04% | |||
| EBITDA | 8.32% | -5.25% | |||
| EPS Basic | 15.93% | -5.19% | |||
| Normalized Basic EPS | 7.28% | -5.99% | |||
| EPS Diluted | 15.93% | -5.19% | |||
| Normalized Diluted EPS | 7.28% | -5.99% | |||
| Average Basic Shares Outstanding | 0.98% | 0.78% | |||
| Average Diluted Shares Outstanding | 0.98% | 0.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||